LIQUID BIOPSY
Dead / Abandoned — Abandoned — failure to respond (as of 29 Jun 2023)
What this means for you
This application is over — abandoned 09 Jun 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97744447
- Mark type
- Stylized text
- Filed
- 06 Jan 2023
- Abandoned
- 09 Jun 2023
- Attorney of record
- Patrick J. Jennings
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic kits consisting primarily of clinical diagnostic reagents and assays for cancer screening
- Class 010 — Medical apparatus: Blood collection kit comprised of blood collecting tubes
- Class 042 — Scientific and technological services: Scientific research for medical purposes in the area of cancerous diseases; structural and functional analysis of genomes; providing a website featuring information in the field of cancerous diseases for scientific purposes
- Class 044 — Medical, beauty and agricultural services: Healthcare services, namely, providing a database in the field of cancer related information and featuring inputting and collection of data and information for diagnostic purposes; medical testing of blood for diagnostic or cancer screening purposes; providing cancer screening services in the nature of providing medical diagnostic testing services consisting primarily of chemical analysis and use of bioinformatics tools for cancer detection; providing a website featuring information in the field of cancerous diseases for diagnostic and cancer screening purposes; providing a website featuring information in the field of cancerous diseases for medical purposes
Owner
- Guardant Health, Inc., Redwood City, CA, US
Prosecution history
- 29 Jun 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 29 Jun 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 29 Jun 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 08 Mar 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 Mar 2023 — NON-FINAL ACTION E-MAILED
- 08 Mar 2023 — NON-FINAL ACTION WRITTEN
- 13 Feb 2023 — ASSIGNED TO EXAMINER
- 30 Jan 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 10 Jan 2023 — NEW APPLICATION ENTERED